Trademark: 90757245
Status Date
Saturday, December 2, 2023
Filing Date
Sunday, June 6, 2021
Published for Opposition
Tuesday, October 11, 2022
5 Medical diagnostic tests comprised of assays and reagents that test for the presence of medical biomarkers present in human blood and body fluids by applying advanced analytics; Medical diagnostic tests comprised of assays and reagents that test for the presence of medical biomarkers present in human blood and body fluids by applying machine learning technology; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, water analysis, and liquid biopsy; Diagnostic assays, reagents, enzymes, and nucleotides for medical or clinical purposes
44 Medical testing for diagnostic or treatment purposes; Medical diagnostic testing, monitoring, and reporting services; Consulting services in the fields of diagnostic medical testing; Providing medical information, consultancy and advisory services;Providing medical testing services and information in the fields of cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases for diagnostic or treatment purposes; Medical testing services, namely, diagnostic testing services for detecting cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases by identifying and analyzing biomarkers for diagnostic or treatment purposes; Providing screening, detection, and monitoring services for cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases
10 Blood collection kit comprised of blood collecting tubes; Blood testing apparatus; Diagnostic apparatus for medical purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in liquid biopsy testing; Diagnostic tests comprising medical apparatus and instruments, namely, liquid biopsy testing systems; Medical diagnostic testing kits containing sterile medical specimen collection tools in the nature of lancets, swabs, saliva collection tubes, and collection cards for the collection of blood, urine, saliva, and feces for use in testing and for monitoring various medical conditions, and also including instructions and return shipping packaging; Testing kits containing medical laboratory research instruments for taking samples of human blood and body fluids for use in detecting cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases
42 Providing medical research information regarding results of testing for various medical conditions; Providing scientific analysis and information regarding the results of laboratory testing in the field of various medical conditions; Laboratory testing services, namely, clinical processing of medical diagnostic testing kits; Medical research; Scientific research for medical purposes in the field of cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases; Providing temporary use of non-downloadable software for use in creating, displaying, sharing and storing information, test results and data in the fields of cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases; Providing online computer databases featuring medical research information in the fields of cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases
Dec 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2023
Sou Extension 2 Granted
Dec 2, 2023
Sou Extension 2 Filed
Dec 2, 2023
Sou Teas Extension Received
Jun 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 5, 2023
Sou Extension 1 Granted
Jun 5, 2023
Sou Extension 1 Filed
Jun 5, 2023
Sou Teas Extension Received
Dec 6, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 11, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 11, 2022
Published For Opposition
Sep 21, 2022
Notification Of Notice Of Publication E-Mailed
Sep 8, 2022
Approved For Pub - Principal Register
Sep 2, 2022
Teas/Email Correspondence Entered
Sep 1, 2022
Correspondence Received In Law Office
Sep 1, 2022
Teas Response To Office Action Received
Mar 2, 2022
Notification Of Non-Final Action E-Mailed
Mar 2, 2022
Non-Final Action E-Mailed
Mar 2, 2022
Non-Final Action Written
Feb 22, 2022
Assigned To Examiner
Oct 6, 2021
Automatic Update Of Assignment Of Ownership
Aug 27, 2021
New Application Office Supplied Data Entered
Jun 9, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
